Mar 10

Vertebral Intraosseous Plasma Rich in Growth Factor (PRGF) Infiltrations as a Novel Strategy for the Treatment of Lumbar Pathology

TOBI Faculty, Dr. Kirchner and colleagues, have recently published their case presentation of a novel strategy for the treatment of degenerative low back pain in a recent issue of the Journal of Orthopedic Surgery and Research.  A primary motivation to adopt minimally invasive cell-based therapies in the field of Orthobiologics to treat degenerative conditions of the spine led this team of researchers and clinicians to present the first reported case description of the utilization of Vertebral Interosseous and Intervertebral disc...

Jul 16

Comparing PRP and prolotherapy in the treatment of SI joint dysfunction

[section_tc][column_tc span='12'][text_tc trigger_pt='0' duration='1000' delay='0']Low back pain (LBP) is a significant source of morbidity that affects a significant portion of the population. While initially a mainstay in therapy, surgical interventions have come under intense scrutiny as research has questioned their efficacy in addressing LBP. Nonspecific LBP (NSLBP) is particularly difficult to treat because multiple etiologies can contribute to ongoing pain. Mechanical dysfunction of the sacroiliac joint (SIJ) has been targeted as a common source of low back pain amenable to...

Jun 2

A Conversation on Regenerative Medicine with Drs. Malanga and Mautner

[section_tc][column_tc span='12'][text_tc trigger_pt='0' duration='1000' delay='0']Regenerative medicine experts and TOBI faculty Dr. Gerry Malanga and Dr. Ken Mautner recently sat down with Dr. Jonothan Halperin to discuss the basics of regenerative medicine as well as the current state of literature possible future directions. We’ve provided a brief synopsis below, but encourage you to dive into this fascinating conversation from two of the thought-leaders in this area.Synopsis:The conversation starts by summarizing the past and current state of regenerative therapies. While these therapies...